The short answer
The often-cited 2003 tripeptide-copper wound study involved rats, not dogs. It is a topical wound model and does not establish that a GHK-Cu pen treats canine skin or coat conditions.
Identify the substance before reading the claims
GHK-Cu is a copper-peptide complex. The identity, carrier and topical route in a study differ from an injectable presentation; findings should not be transferred between them without supporting evidence.
| Study | Species and design | What it measured | Limitations |
|---|---|---|---|
| Canapp et al., 2003 | 24 adult male rats; experimental ischaemic skin wounds | Compared a topical tripeptide-copper preparation with vehicle and untreated controls; reported faster wound-area reduction in that model. | This was not a canine trial, an injection study or a coat-health study. The authors called for clinical evaluation in other species. |
Source checked 13 October 2026 against the primary bibliographic record and abstract. This is a selected-source summary, not a systematic review or an independent veterinary endorsement. The author and publisher are PET157; no external clinical reviewer is claimed.
What to ask next
Ask your veterinarian about the diagnosis, established care and how the cited species, formulation and outcome relate to the question. Research information is separate from Australian approval, lawful supply and individual clinical suitability. No administration instructions are provided here.